Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
MRNA - Moderna, Inc.
Market Cap 42.02B P/E 9.48 EPS this Y 22.20% Ern Qtrly Grth -
Income -5.87B Forward P/E -27.08 EPS next Y 16.10% 50D Avg Chg -11.00%
Sales 5.05B PEG 0.13 EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book 2.24 EPS next 5Y -51.34% 52W High Chg -49.00%
Recommedations 2.70 Quick Ratio 3.77 Shares Outstanding 384.40M 52W Low Chg -
Insider Own 9.52% ROA -15.42% Shares Float 347.11M Beta 1.67
Inst Own 72.69% ROE -40.94% Shares Shorted/Prior 27.61M/25M Price 110.22
Gross Margin -62.99% Profit Margin -116.18% Avg. Volume 3,254,514 Target Price 101.94
Oper. Margin -565.56% Earnings Date Oct 31 Volume 4,434,575 Change -3.26%
Healthcare | Biotechnology | United States
About Moderna, Inc.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna, Inc. News
11/15/24 Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS
11/15/24 How analysts are reacting to RFK Jr. as Trump's HHS pick
11/15/24 Update: Moderna, Novavax, Pfizer Shares Fall on Nomination of Anti-Vaxxer as US Health Secretary
11/15/24 Moderna, Inc. (MRNA): Among 12 High Growth Large Cap Stocks to Buy Now
11/15/24 Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
11/15/24 Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
11/15/24 Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too
11/15/24 Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary
11/15/24 RFK Jr. News Hits Global Pharma Stocks
11/15/24 Trending tickers: Tesla, Alibaba, Pfizer, Domino's and Disney
11/15/24 Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna and Novavax Stocks Slide.
11/14/24 Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
11/14/24 Is Moderna Stock A Sell After A Key Nuance Undercut Its Third-Quarter Beat?
11/13/24 The Oncology Bet Is Already Paying Off For Pfizer
11/12/24 Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals
11/12/24 FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
11/12/24 Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year
11/11/24 Moderna’s mRESVIA vaccine gains Health Canada approval
11/09/24 Earnings Beat: Moderna, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
11/08/24 Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
MRNA Chatroom

User Image Gallium7 Posted - 48 minutes from now

$MRNA so, when does MRNA-4157 get accelerated approval? Thanksgiving or Christmas break? Given the drop, my bet is on Thanksgiving.

User Image taxplanr Posted - 29 minutes ago

All those revealing China connections is entertaining $BNTX $PFE $MRNA https://petermcculloughmd.substack.com/p/elon-musk-declares-the-hammer-of

User Image cielo1 Posted - 1 hour ago

$MRNA $<30 this week, way too controversial, way more options to invest in!

User Image Samishere Posted - 3 hours ago

$MRNA

User Image CheapStockInvestor Posted - 3 hours ago

$MRNA Received my booster shot from moderna for the new variant. I got like 7 so far.

User Image SPACE350PT Posted - 5 hours ago

$MRNA $60-$70 comes fast

User Image CheapStockInvestor Posted - 6 hours ago

$MRNA The future is preventative care rather than the reactionary care today. Eating great, exercising, and getting vaccinated much better and cheaper than getting hospitalized and paying thousands or hundreds of thousands to get a cure. Paying a hundred for a vaccine and staying in shape is the actual answer to reducing Healthcare costs for everybody. Moderna isn't going anywhere. You will inject moderna into your body and you will like it. Moderna will be all around you.

User Image FindingFacts Posted - 8 hours ago

$MRNA Shorts are bedding with a science-denier and a radical, so shorts will be proved to be trapped to buy back at $50.

User Image VelvetBarbie Posted - 9 hours ago

$MRNA buh bye

User Image georgeyann Posted - 9 hours ago

$MRNA Promoting mRNA covid vaccines is tantamount to killing people! Your moron!

User Image Doozio Posted - 9 hours ago

$mrna 🐑👀

User Image GotMe4Life Posted - 9 hours ago

$MRNA

User Image ___dog___ Posted - 9 hours ago

$MRNA who bought at 460?

User Image LoveFest24 Posted - 10 hours ago

$MRNA $LLY ya got caught https://www.youtube.com/watch?v=O1K4zNaVKqc&ab_channel=WATOP

User Image CheapStockInvestor Posted - 11 hours ago

$MRNA Bears need to take into consideration the CMV data coming our this quarter. It's a 3-5 TAM drug with no competitors, solid revenue stream other than covid, and verifies moderna can create vaccines other than the covid one. It's already dropped 30% since trump became president elect and dropped 15% since the official choice being rfk. I'd be careful shorting this right now

User Image Alexxe28 Posted - 11 hours ago

$MRNA Doesn't matter, at the time of voting the price will sit already @net cash equivalents of $20.39 per share.

User Image BigRun Posted - 11 hours ago

$MRNA My guess is RFK Jr will not have the votes from the Senate Finance Committee to to on the role. Price will immediately shoot to $50 and continue to grow from there.

User Image BigDee73 Posted - 11 hours ago

$MRNA $NVAX $PFE

User Image bolo44 Posted - 13 hours ago

$MRNA RFK shorted this scam!!

User Image GotMe4Life Posted - 13 hours ago

$MRNA this product roadmap = $10 SP https://www.modernatx.com/en-US/research/product-pipeline

User Image CheapStockInvestor Posted - 13 hours ago

$MRNA The future is eating healthy, exercise, and preventative care such as vaccines. This is the true common sense approach

User Image georgeyann Posted - 13 hours ago

$MRNA doesn’t be fooled again! Sell NOW! $5 or less soon

User Image CheapStockInvestor Posted - 13 hours ago

$MRNA Expecting a 50% share price increase after positive CMV data this quarter. Glta

User Image Slifka Posted - 14 hours ago

$MRNA $60 next week. Slam dunk.

User Image Slifka Posted - 15 hours ago

$MRNA vs $NVDA chart

User Image Crash_Bash Posted - 15 hours ago

$PFE $MRNA $NVAX this is the guy who will lead more uneducated Americans down to grave much faster and have more death amongst children... what a bunch of clowns running the country

User Image EEVVIILL Posted - 15 hours ago

$MRNA Easily in takeover target territory

User Image Topdog007 Posted - 15 hours ago

$NVAX $MRNA Hi Andre. Your comments are not wrong however, RNA vaccines are a major space and not going anywhere. They are highly effective and time will provide you all the proof you need to see it. Moderna should be trading above $100 easily, the US is becoming a rigged corrupt country and they will suffer inevitably

User Image GotMe4Life Posted - 16 hours ago

$MRNA Racism and Elitism aren't good looks

User Image Buybuyamericanpie Posted - 16 hours ago

$MRNA https://www.cnn.com/2024/11/16/health/mpox-clade1-california-first/index.html

Analyst Ratings
JP Morgan Neutral Aug 15, 24
Deutsche Bank Hold Aug 6, 24
RBC Capital Sector Perform Aug 5, 24
RBC Capital Outperform Aug 2, 24
Goldman Sachs Buy Aug 2, 24
Barclays Overweight Aug 2, 24
Piper Sandler Overweight Aug 2, 24
Needham Hold Aug 1, 24
Needham Hold Jun 28, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hoge Stephen President President Dec 27 Sell 100.01 45,000 4,500,450 1,531,063 12/28/23
Klinger Shannon Thyme Chief Legal Officer Chief Legal Officer Dec 07 Sell 79.09 563 44,528 7,912 12/11/23
AFEYAN NOUBAR Director Director Nov 01 Sell 75.73 10,000 757,300 2,146,931 11/03/23
AFEYAN NOUBAR Director Director Oct 25 Sell 77.49 10,000 774,900 2,156,931 10/27/23
AFEYAN NOUBAR Director Director Oct 11 Sell 104.26 15,000 1,563,900 2,166,931 10/13/23
Mock James M Chief Financial Offi.. Chief Financial Officer Oct 05 Sell 102.5 2,858 292,945 2,952 10/10/23
AFEYAN NOUBAR Director Director Oct 04 Sell 102.05 15,000 1,530,750 2,181,931 10/06/23
AFEYAN NOUBAR Director Director Sep 27 Sell 99.37 10,000 993,700 2,196,931 09/29/23
AFEYAN NOUBAR Director Director Sep 20 Sell 104.9 15,000 1,573,500 2,206,931 09/22/23
AFEYAN NOUBAR Director Director Sep 13 Sell 111.17 15,000 1,667,550 2,221,931 09/15/23
AFEYAN NOUBAR Director Director Sep 06 Sell 108.08 15,000 1,621,200 1,982,209 09/08/23
Garay Arpa Chief Commercial Off.. Chief Commercial Officer Sep 05 Sell 108.4 574 62,222 3,113 09/07/23
AFEYAN NOUBAR Director Director Aug 30 Sell 115.96 15,000 1,739,400 1,997,209 09/01/23
AFEYAN NOUBAR Director Director Aug 23 Sell 114.78 15,000 1,721,700 2,012,209 08/25/23
AFEYAN NOUBAR Director Director Aug 16 Sell 97.71 10,000 977,100 2,027,209 08/18/23
Hoge Stephen President President Aug 17 Sell 100.00 15,000 1,500,000 1,587,579 08/18/23
AFEYAN NOUBAR Director Director Aug 02 Sell 112.08 15,000 1,681,200 2,037,209 08/04/23
AFEYAN NOUBAR Director Director Jul 26 Sell 120.47 15,000 1,807,050 2,052,209 07/28/23
AFEYAN NOUBAR Director Director Jul 19 Sell 125.16 15,000 1,877,400 2,067,209 07/21/23
AFEYAN NOUBAR Director Director Jul 12 Sell 125.9 15,000 1,888,500 2,082,209 07/14/23
AFEYAN NOUBAR Director Director Jul 05 Sell 125.84 15,000 1,887,600 2,097,209 07/07/23
AFEYAN NOUBAR Director Director Jun 28 Sell 121.33 15,000 1,819,950 2,112,209 06/30/23
AFEYAN NOUBAR Director Director Jun 21 Sell 122.45 15,000 1,836,750 2,127,209 06/23/23
AFEYAN NOUBAR Director Director Jun 14 Sell 126.73 15,000 1,900,950 2,142,209 06/16/23
AFEYAN NOUBAR Director Director Jun 07 Sell 126.17 15,000 1,892,550 2,157,209 06/09/23
Garay Arpa Chief Commercial Off.. Chief Commercial Officer Jun 05 Sell 125.75 2,290 287,968 2,547 06/07/23
AFEYAN NOUBAR Director Director May 31 Sell 127.7 15,000 1,915,500 2,172,209 06/02/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 26 Sell 131.62 80,000 10,529,600 5,411,946 04/28/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 26 Option 0.99 80,000 79,200 5,451,946 04/28/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 19 Sell 142.81 80,000 11,424,800 5,411,946 04/21/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 19 Option 0.99 80,000 79,200 5,451,946 04/21/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 05 Sell 155.78 80,000 12,462,400 5,411,946 04/07/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Apr 05 Option 0.99 80,000 79,200 5,451,946 04/07/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Mar 22 Sell 150.21 80,000 12,016,800 5,411,946 03/24/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Mar 22 Option 0.99 80,000 79,200 5,451,946 03/24/23
AFEYAN NOUBAR Director Director Mar 01 Sell 139 10,000 1,390,000 2,187,209 03/03/23
Hoge Stephen President President Feb 28 Sell 138.03 1,072 147,968 1,629,031 03/02/23
Hoge Stephen President President Feb 28 Option 0 2,410 1,630,103 03/02/23
AFEYAN NOUBAR Director Director Feb 15 Sell 173.17 10,000 1,731,700 2,207,209 02/17/23
Hoge Stephen President President Feb 09 Sell 163.9 245 40,156 1,627,693 02/13/23
Hoge Stephen President President Feb 09 Option 0 522 1,627,938 02/13/23
AFEYAN NOUBAR Director Director Feb 08 Sell 166.92 20,000 3,338,400 2,217,209 02/10/23
AFEYAN NOUBAR Director Director Jan 25 Sell 194.33 10,000 1,943,300 2,237,209 01/27/23
AFEYAN NOUBAR Director Director Jan 18 Sell 200.20 10,000 2,002,000 2,247,209 01/20/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 18 Sell 198.64 80,000 15,891,200 5,411,946 01/20/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 18 Option 0.99 80,000 79,200 5,451,946 01/20/23
AFEYAN NOUBAR Director Director Jan 11 Sell 188.57 10,000 1,885,700 2,257,209 01/13/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 184.24 80,000 14,739,200 5,411,946 01/13/23
Bancel Stephane Chief Executive Offi.. Chief Executive Officer Jan 11 Option 0.99 80,000 79,200 5,451,946 01/13/23
AFEYAN NOUBAR Director Director Jan 04 Sell 182.15 10,000 1,821,500 2,267,209 01/06/23